Astrana Health, Inc. to Participate in Upcoming Investor Conference
ALHAMBRA, Calif.,Dec. 19, 2024/PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that leadership is participating in the J.P. Morgan 2025 Healthcare Conference, being held in San Francisco, on Tuesday, January 14, 2024, including a presentation at 10:30am PT from President and CEO of Astrana Health, Brandon Sim. The webcast link and related presentation materials will be available in the "IR Calendar" section of the Company's website:https://ir.astranahealth.com/news-events/ir-calendar.
About Astrana Health, Inc.
Astrana is a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver high quality care to patients in a cost-effective manner.
Headquartered in Alhambra, California, Astrana serves over 12,000 providers and over 1.1 million Americans in value-based care arrangements. Its subsidiaries and affiliates include management services organizations (MSOs), affiliated independent practice associations (IPAs), accountable care organizations (ACOs), and care delivery entities across primary, multi-specialty, and ancillary care. For more information, please visitwww.astranahealth.com.
FOR MORE INFORMATION, PLEASE CONTACT:Investor Relations(626) 943-6491Asher Dewhurst, ICR Healthcareinvestors@astranahealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/astrana-health-inc-to-participate-in-upcoming-investor-conference-302336639.html
SOURCE Astrana Health, Inc.
Released December 19, 2024